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The cyclic di-GMP (c-di-GMP) second messenger represents
a signaling system that regulatesmany bacterial behaviors and is
of key importance for driving the lifestyle switch betweenmotile
loner cells and biofilm formers. This review provides an up-to-
date compendium of c-di-GMP pathways connected to biofilm
formation, biofilm-associated motilities, and other functional-
ities in the ubiquitous and opportunistic human pathogen Pseu-
domonas aeruginosa. This bacterium is frequently adopted as a
model organism to study bacterial biofilm formation. Impor-
tantly, its versatility and adaptation capabilities are linkedwith a
broad range of complex regulatory networks, including a large
set of genes involved in c-di-GMP biosynthesis, degradation,
and transmission.
Bacteria can live as planktonic cells exploring aqueous envi-
ronments or as a sessile biofilm community. The switch from
planktonic to sessile occurs when, under propitious conditions,
individual cells encounter a surface and undergo a series of
dramatic physiological, metabolic, and phenotypic changes.
Among these changes are the slowdown of metabolic activities
and the production of an extracellular matrix, a complex mix-
ture of exopolysaccharides, proteins, and nucleic acids (1). In
the case of pathogens, the two bacterial lifestyles also differ in
terms of virulence factor production and infection strategies.
Although planktonic cells cause fulminant acute infections, the
formation of a biofilm correlates with deep-rooted chronic
infections and resistance to both phagocytosis and antimicro-
bial agents (2).
Cyclic di-GMP (c-di-GMP)3 is recognized as an intracellular
signaling molecule coordinating the “lifestyle transition” from
motility to sessility and vice versa (i.e. dispersion) (3). The cor-
relation between high c-di-GMP concentration in the cell and
biofilm formation or between low c-di-GMP levels andmotility
has been demonstrated in several bacteria species, e.g. Esche-
richia coli, Pseudomonas aeruginosa, and Salmonella enterica
serovar Typhimurium (4). P. aeruginosa biofilms are estimated
to contain on average 75–110 pmol of c-di-GMPpermg of total
cell extract, whereas planktonic cells contain less than 30 pmol
mg1 (5). This concept is widely accepted but does not include
the multiplicity of c-di-GMP transmission cascades operating
during biofilm. Biofilm determinants modulated by c-di-GMP
range from flagella rotation to type IV pili retraction, exopoly-
saccharide production, surface adhesin expression, antimicro-
bial resistance and other stress responses, secondarymetabolite
production, and biofilm dispersion (3). How do we reconcile
the global effect of the intracellular c-di-GMPconcentration on
stimulating the biofilm lifestyle with the discrete actions of
c-di-GMP on biofilm formation? Biofilm formation is consid-
ered as a developmental process that includes attachment to
and movement on the surface, formation of microcolonies,
maturation, and ultimately dispersal (1, 6, 7). It is proposed that
cells use c-di-GMP as a checkpoint to proceed through the
distinct stages of biofilm development until they fully commit
to the biofilm lifestyle, although they may still be offered the
choice to revert the decision at any time (3, 8).
The c-di-GMPMetabolism
The levels of c-di-GMP in the cell are modified by the rate of
its synthesis and degradation. Themolecule is synthesized from
two molecules of GTP by enzymes called diguanylate cyclases
(DGCs) and is degraded into 5-phosphoguanylyl-(3-5)-
guanosine (pGpG) and/or GMP by phosphodiesterases (PDEs)
(Fig. 1A). Using bioinformatics, biochemical, and structural
approaches, the catalytic domains ofDGCs andPDEshave been
identified and characterized: the former carrying a GGDEF
active site motif, and the latter carrying either EAL or HD-GYP
domains (9, 10). These domains can stand alone in a protein or
can be present in association with receiver or transmission
domains, suggesting amodulation of their enzymatic activity in
response to external/internal signals, whereas several have
multiple hydrophobic segments, suggesting membrane local-
ization (Fig. 1B). This indicates a possible post-translational
regulation of DGCs and PDEs that may segregate their activity
temporally or spatially. Moreover, GGDEF and EAL domains
can both be present in the same protein. In these so-called
“hybrid” proteins, either only one of the two domains is catalyt-
ically active, the other having acquired a regulatory function, or
a third regulatory domain is present, probably disjoining the
activity of the GGDEF and EAL domains (11, 12). Recently,
examples of proteins with dual DGC and PDE activities have
been described, shedding some light on this “biochemical
conundrum” (13–15). In P. aeruginosa, the GGDEF and the
EALdomains ofMucR are activated differently so that in plank-
tonic cells,MucR functions as aDGCand as a positive regulator
of alginate biosynthesis, whereas in biofilms, it functions as a
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PDE and is a positive regulator of biofilm dispersal induced by
nitric oxide or glutamate (16).
Large-scale genome sequencing led to the discovery that
GGDEF- and EAL-containing proteins are nearly ubiquitous in
the bacterial kingdom and that bacterial genomes containmul-
tiple copies of genes encoding GGDEF, EAL, or HD-GYP
domain-containing proteins (17). A census of all the GGDEF,
EAL, andHD-GYP domains in bacterial genomes is available at
http://www.ncbi.nlm.nih.gov/Complete_Genomes/c-di-
GMP.html (18). The abundance of DGCs and PDEs in a
genomemay be correlated to the number of complex cellular
functions linked with c-di-GMP signaling and to the diver-
sity of possible signals coordinating these functions. The
P. aeruginosa genome encodes one of the highest numbers of
DGCs and PDEs: 18 GGDEF, 5 EAL, 16 GGDEF/EAL, and 3
HD-GYP predicted proteins (supplemental Table S1).
DGCs: GGDEF Domain Proteins
DGCs function as homodimers. The GGDEF catalytic site is
placed at the dimer interface and is involved in the binding of
two molecules of GTP and in their conversion into c-di-GMP,
with Mg2 as cofactor. Five amino acids upstream of the
GGDEF active site is the inhibitory site (I-site) RXXD, where
the feedback inhibition of the cyclase activity occurs. Binding of
c-di-GMP at the I-site prevents the formation of enzymatically
active DGC dimers (19). The first experimental demonstration
of a DGC activity comes from the work on PleD, a response
regulator in Caulobacter crescentus (20). Nowadays the PleD
activity is well defined together with its receiver (REC) domain
and the phosphorylation-induced dimerization. In P. aerugi-
nosa, the first biochemical characterization of a DGC stems
from the work on WspR, which contains a REC-GGDEF
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FIGURE 1.Molecular basis of c-di-GMP signaling in P. aeruginosa. A, c-di-GMP is synthesized by diguanylate cyclases (green) that carry GGDEF domains and
degraded by phosphodiesterases (red) that carry either EAL or HD-GYP domains. EAL phosphodiesterases linearize c-di-GMP into pGpG, which is successively
hydrolyzed into 2 GMPmolecules primarily by the oligoribonuclease Orn (orange) (34, 35). HD-GYP-phosphodiesterases are proposed to perform both steps
of the c-di-GMP degradation process (31). Feedback inhibition mechanisms are illustrated by gray lines. In the cell, c-di-GMP regulates cellular processes at
different levels (transcriptional, post-transcriptional, and post-translational). The diversity of c-di-GMP-binding receptors and effectors (blue) is the key of the
c-di-GMP pleiotropic mechanisms. B, spatial localization signals and partner domain occurrence for GGDEF, EAL, and HD-GYP proteins of P. aeruginosa. Table
based on the work of Seshasayee et al. (17) *: The sets of proteins corresponding to each of the category are not mutually exclusive. Organization of classes is
in agreement as described previously (17). TM helices, transmembrane helices. C, pie chart illustrating numerical proportion of GGDEF, EAL, and HD-GYP
proteins in P. aeruginosa.
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domain organization (supplemental Table S1). The DGC was
named after its regulatory role on the P. aeruginosa wrinkly
spreader phenotype that is correlated with a thick biofilm due
to an increased production of exopolysaccharides (21). The
control of WspR activity occurs by three different routes that
are proposed to occur sub-sequentially. First, upon sensing
growth on the surface, the Wsp signal transduction complex
phosphorylatesWspRand triggers c-di-GMPsynthesis (21, 22).
In turn, the WspR phosphorylation triggers subcellular WspR
oligomerization and cluster formation, which further increases
the DGC activity (23). Finally, the feedback inhibition ofWspR
activity occurs by c-di-GMP binding at the I-site (24). The
mechanisms of WspR regulation are supported by structural
studies, which revealed that, in solution, the protein can exist in
three stable forms: a globular dimer (active), a tetramer (more
active), and an elongated dimer (less active due to c-di-GMP
binding) (25, 26).
PDEs: EAL or HD-GYP Domain Proteins
The EAL domain hydrolyzes c-di-GMP into linear pGpG
(Fig. 1). Contrary toDGCs, the EAL activity of PDEs seems to be
independent of protein oligomerization, whereas it is depen-
dent on binding metal ions (requiring Mg2 or Mn2 and
inhibited by Ca2 and Zn2) (27). The glutamate residue (E) in
the EAL signature motif is essential, whereas a change of the
alanine residue (A) into tyrosine or valine (ETL and EVL) still
sustains the enzymatic activity. InP. aeruginosa, theCheY-EAL
domain protein RocR was identified as a response regulator in
the RocSAR signaling system (28). This system is composed of a
membrane sensor RocS1 and two response regulators, RocA1
and RocR. RocR activity is triggered by phosphorylation at the
CheY domain, and the protein competes with RocA1 for the
phosphoryl transfer from the RocS1 sensor. Overall, the Roc
system regulates biofilm formation and virulence genes expres-
sion (cup fimbriae gene clusters and type III secretion system
genes) (28, 29).
HD-GYP domain-containing proteins belong to the HD
superfamily of metal-dependent phosphohydrolases (11). This
enzyme hydrolyzes c-di-GMP in a two-step reaction, produc-
ing as a final product two molecules of GMP (Fig. 1). Contrary
to GGDEF and EAL proteins, this class of enzyme is not ubiq-
uitous in bacteria, but still widely distributed (18). The first
biochemical studies on HD-GYP proteins were conducted on
the RpfG PDE fromXanthomonas campestris (30). In P. aerugi-
nosa, two of the three HD-GYP proteins (PA4108, PA4781, and
PA2572) were shown to have a PDE activity in vivo and in vitro
(supplemental Table S1) (31, 32). The structure of PA4781 has
been resolved, showing that PA4781 preferentially binds to
pGpG over c-di-GMP, and the low rate in hydrolyzing c-di-
GMP brought into question its primary work as a genuine PDE
(33). Interestingly, pGpG is also a signaling molecule, and it is
proposed as a possible alternative to c-di-GMP in certain con-
ditions (3, 31). Finally, the 3-5exoribonuclease Orn has been
identified in P. aeruginosa as primarily responsible for the
pGpG cleavage into two GMP molecules (34, 35).
Discrete Role of DGCs and PDEs on P. aeruginosa Biofilm
Formation and during Infection
Besides WspR and RocR, described previously, other DGCs
and PDEs have been reported as key players in P. aeruginosa
biofilm formation. Careful examination of dgc and pdemutant
phenotypes, combined with epistasis analysis, pointed at spe-
cific features about the role of, for example, SadC and RoeA
(DGC) or BifA (PDE) (supplemental Table S1). This resulted in
a more global understanding of their relative importance at
different stages of the biofilm development process (36, 37). In
Fig. 2, we illustrate this concept by including all the P. aerugi-
nosa DGCs and PDEs that have been in one way or another
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FIGURE 2. Coordinated action of c-di-GMP signaling pathways and two-component system cascades in the control of P. aeruginosa biofilm develop-
ment. In the laboratory, biofilm formation is shown tobea cyclic process that initiateswith attachment to the surfaceof planktonic bacteria (first reversible and
then irreversible). A bacteria microcolony is subsequently formed, which evolves into a mature mushroom-shaped macrocolony until the biofilm-associated
cells disperse to resume again a planktonic lifestyle. Planktonic, biofilm, and dispersed cells possess distinct physiological stages (green, black, and red outline,
respectively) (1, 7). The upper panel illustrates DGC (green), PDE (red), and c-di-GMP receptors/effectors (blue) and the developmental stage in which they are
proposed to act. Specific references to eachDGC/PDE/effector are available in supplemental Tables S1 and S2. The lower panel illustrates biofilm stage-specific
two-component regulatory systems (45). The gradient of the gray panels in the background of the figure indicates increasing intracellular c-di-GMP levels (also
indicated with *, **, ***, and ****).
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associatedwith biofilm formation.At least fiveDGCshave been
described to specifically control the transition from planktonic
to surface-associated growth: WspR, SadC, RoeA, SiaD, and
YfiN/TpbB (21, 36–39). Instead, the GcbA and NicD DGCs or
the DipA (Pch), RbdA, and NbdA PDEs have been linked to
biofilm dispersal (5, 40–44).
The sequential intervention of these enzymes reveals that
c-di-GMP pathways are well coordinated, organized, insulated,
and tuned by global regulatory networks (45). These networks
repress or activate distinct c-di-GMP pathways in a defined
temporal window. In P. aeruginosa, this concept is supported
through several examples such as the connection between c-di-
GMP signaling and the Gac/Rsm cascade for the control of
biofilm formation (Fig. 3), between c-di-GMP signaling and the
SagS pathway for the regulation of biofilm antimicrobial resis-
tance, or between c-di-GMP signaling and the Las-mediated
quorum-sensing system for the control of biofilm formation
and collective motilities (44, 46–48).
P. aeruginosa is predominant in chronic infection of cystic
fibrosis patients, where the bacterium persists for many years,
creating life-threatening lung damage. Over the course of long-
term infections, P. aeruginosa undergoes extensive genetic and
phenotypic adaptation to the lung environment, resulting in a
less virulent state with increased production of biofilm (49). A
consequence of the P. aeruginosa adaptation to the lungs is its
phenotypic heterogeneity, e.g. the mucoid or the small colony
variant (SCV) phenotype (50). In general, SCV colonies appear
small, slow growing, and more resistant to several classes of
antibiotics, with an increased production of exopolysaccha-
rides and high c-di-GMP levels (50, 51). The c-di-GMP signal-
ing has been proposed to be instrumental for SCV formation
because overexpression/activation of DGC such as WspR or
YfiN (TbpB) induces the SCVphenotype, whereasmutations in
the wsp and yfi systems were identified in SCVs isolated from
cystic fibrosis patients. YfiN is a membrane-anchored DGC,
which up-regulates the pel and psl exopolysaccharide operons
(39), whereas its activity is repressed by the YfiR periplasmic
protein (52). YfiB is an outer membrane lipoprotein and an
antagonist of YfiR (53). Finally, exposure to sub-inhibitory con-
centration of antibiotic triggers SCVs formation (54, 55), and in
the case of kanamycin, this effect is linked to c-di-GMP via the
PvrR PDE (55).
Molecular Mechanisms of c-di-GMP Regulation
The regulation of cellular functions by c-di-GMP occurs at
multiple levels, including (i) allosteric regulation of an enzyme
activity or protein function, (ii) regulation of gene expression
through modulation of a transcription factor, and (iii) regula-
tion of gene expression by direct interaction with noncoding
RNAmolecules (riboswitches). The molecular bricks by which
c-di-GMP builds these regulatory connections are constituted
by an array of different c-di-GMP-binding receptors or c-di-
GMP effector molecules. We define here c-di-GMP receptors
as those molecules that detect c-di-GMP levels in the cell and
consequently translate the information into the activation of
a specific cellular response/signaling pathway. Instead, c-di-
GMP effectors are defined as proteins whose activity changes
allosterically upon c-di-GMP binding and consequently regu-
late a defined interacting target protein. A list of identified c-di-
GMP receptors/effectors in P. aeruginosa is presented in sup-
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FIGURE3.TheGac/Rsmcascade inP. aeruginosa is genetically linked toc-di-GMPthroughSadC.TheGacS/GacA two-component system ispromoting the
expression of two small regulatory RNAs, RsmY and RsmZ, which sequester the translational repressor RsmA. Titration of RsmA induces the production of
sessile and biofilm determinants, whereas free RsmA leads to a planktonic and more virulent lifestyle (45, 99). Several additional regulators modulate the
Gac/Rsm system, such as the two hybrid sensors RetS and LadS, as well as the histidine phosphotransfer protein HptB and other pathways. The elevated
concentration of c-di-GMP in a hyperbiofilm-forming retSmutantwas the first hint of the link between theGac/Rsmand the c-di-GMPpathways (100). Later on,
themolecular details of the linkwere elucidated: SadC, a DGCwhose production is repressed by RsmA, is a central player for the Gac/Rsm regulation of biofilm
formation (46). It appears therefore evident that the c-di-GMP signalingnetwork and theGsc/Rsmcascade are not independent to eachother and that they are
both instrumental for a proper development of the biofilm.
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plemental Table S2. Among the known c-di-GMP-binding
motifs, we include inactive GGDEF, EAL, HD-GYP domains,
PilZ domains, and other less characterized examples (11, 56).
In P. aeruginosa, PelD is a c-di-GMP receptor whose expres-
sion and binding to c-di-GMP are required for Pel polysaccha-
ride production (57). PelD is an innermembrane protein with a
GAF domain and a degenerated GGDEF domain with a con-
served I-site (supplemental Table S2). The binding of c-di-
GMP to PelD occurs at the I-site (57). How the binding stimu-
lates Pel production and/or secretion remains unclear. One can
speculate that the c-di-GMP-bound formof PelD interactswith
the Pel machinery in a way that induces conformational
changes which stimulate exopolysaccharide transport (58, 59).
PilZ domains contain two conservedmotifs: anRXXXRmotif
with two conserved arginine residues surrounding one of the
c-di-GMP guanine and a DXSXXG motif that surrounds the
other guanine (60). Alg44 is a membrane-associated protein
with a cytoplasmic PilZ domain. This protein binds c-di-GMP
and is required for P. aeruginosa alginate production (61, 62).
Although inactive DGCs, PDEs, and PilZ domains can be
recognized in silico, other effectors are challenging to identify
using bioinformatics prediction. A number of transcriptional
regulators have been identified as c-di-GMP receptors. In
P. aeruginosa, FleQ is an enhancer-binding protein that at low
levels of c-di-GMP is the master activator of flagellar gene
expression (63). Homologs of FleQ are present in all Pseudomo-
nas species and inmany flagellated gamma-proteobacteria (64).
FleQ does not possess a PilZ domain, but c-di-GMP competi-
tively inhibits FleQ ATPase activity by interacting with the
ATP-binding site (65). At high levels of intracellular c-di-GMP,
the binding of the molecule to FleQ converts its function as a
repressor of the pel, psl, and cdr genes, involved in production
of exopolysaccharides and adhesins, into an activator (66).
Another c-di-GMP-responsive transcriptional regulator of
P. aeruginosa is BrlR (67). BrlR participates in the resistance of
biofilm cells to antimicrobial agents by increasing the expres-
sion of genes encoding multidrug efflux pumps (68, 69). Inter-
estingly, BrlR has a stronger binding affinity for c-di-GMP than
FleQ (as characterized by a Kd of 2.2 M and of 15–20 M
respectively; supplemental Table S2), which suggests that BrlR
activation occurs at lower c-di-GMP levels and at earlier stages
in the biofilm development process as compared with FleQ
(67). In general, determination of the affinity constants of the
different receptors or effectors for c-di-GMP can be considered
as useful information to determine at which global levels of
c-di-GMP they are activated and by extension within which
physiological window they act. Finally, c-di-GMP could also act
as a competitive inhibitor for certain enzymes capable of catab-
olizing ATP, such as the FliI flagellar ATPase (70).
The hunt for identifying new c-di-GMP-binding proteins is
ongoing, and both a priori and a posteriori (or targeted)
approaches are being employed. A priori approaches are based
on affinity pulldown assays using c-di-GMP-conjugated Sep-
harose resin, biotin, or a tripartite c-di-GMP capture com-
pound to enrich c-di-GMP-binding proteins from whole cell
lysates (71–73). The differential radial capillary action of ligand
assay (DRaCALA) is also used to systematically screen protein
expression libraries for their c-di-GMP binding activity
(74). Alternatively, the a posteriori approaches are “educated
guesses,” in which gene products functionally associated with
c-di-GMP-regulated processes are tested for c-di-GMPbinding
via several biochemical assays, among them DRaCALA, iso-
thermal titration calorimetry, and a peptide array approach
(74–76).
The Specificity of c-di-GMP Signaling
A pioneering analysis of all GGDEF and EAL domain-con-
taining proteins from two P. aeruginosa strains (PAO1 and
PA14), using transposon mutant libraries or strains overex-
pressing dgc/pde genes, revealed that DGCs or PDEs are not
redundant and have a different impact on biofilm formation or
cytotoxicity (77). Several plausible explanations are proposed
for the partial loss or gain of a specific phenotype when deleting
a dgc or a pde gene. One is that DGCs and PDEs are differen-
tially controlled at the level of gene expression or enzyme activ-
ity and therefore could have a distinct impact on the global pool
of c-di-GMP. Another is related to the degree of c-di-GMP
signaling specificity and the existence of local c-di-GMP pools
in the cell.
c-di-GMP is a small molecule and presumably diffuses freely
in the bacterial cytoplasm. In such a context, all DGCs and
PDEs may affect the pool of c-di-GMP uniformly throughout
the cell. The degree of c-di-GMP-mediated responses is then
possibly determined by the binding affinity of c-di-GMP for
different effectors, which in turn leads to various outputs and
phenotypes.
The low specificity model does not clash with the idea of a
temporal sequestration of DGCs and PDEs. Temporal seques-
tration is reached by modulation of dgc or pde gene expression
at a defined time period, in response to environmental or cel-
lular alterations through functional association to specific reg-
ulatory networks. In P. aeruginosa, for example, a case can be
made for the repression of SadC by the Gac/Rsm cascade (46),
the nutrient-induced activation of the NicD/BdlA/DipA cas-
cade (5), or the presence of Wsp and Yfi multi-protein com-
plexes that control WspR and YfiN DGCs activity, respectively
(21, 39, 53).
An alternative hypothesis that may result in highly specific
signaling is that each individual DGC and PDE regulates only a
subset of c-di-GMP-regulated behaviors. The way this may be
achieved is via molecular mechanisms that sequester the signal
(c-di-GMP pool) in multi-protein complexes or at distinct cel-
lular sites. An example is the PleD polar sequestration during
cell division in C. crescentus (20), the YcgR flagellar motor con-
trol in E. coli and Salmonella (78, 79), the PilZ-FimXEAL-c-di-
GMP complex of Xanthomonas citri (80), the c-di-GMP
dependent localization mechanism of LapA in Pseudomonas
fluorescens (81), or the WspR subcellular clustering in
P. aeruginosa (23). Interesting lessons on signaling molecule
compartmentalization can be taken from cAMP signaling stud-
ies in eukaryotes, where the creation of cAMP compartments is
achieved mainly by localization of PDEs (82).
It becomes obvious that understanding regulatory mecha-
nisms of DGCs and PDEs is not as simple as measuring global
c-di-GMP levels in the cell, and c-di-GMP-dependent control
involves highly complex and tightly regulated signaling sys-
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tems. Low and high signaling specificity could not be mutually
exclusive. In the context of c-di-GMP regulation of localized
structural machineries, such as flagella or type IV pili, it is rea-
sonable to think that themaintenance of a local c-di-GMP pool
would guarantee a more rapid and efficient control of their
activity (78–80). Instead, for the overall development of a bio-
film, the global c-di-GMP pool may guarantee coordination
and cross-talking between multiple pathways (Fig. 2).
Emerging Challenges in c-di-GMP Signaling Research
Novel and original observations on c-di-GMP signaling in
P. aeruginosa have recently emerged and have raised new fun-
damental and challenging questions.
Heterogeneity of c-di-GMP Levels in Individual Cells
A FRET-based biosensor has been recently constructed and
an asymmetrical distribution of c-di-GMPwas observed during
P. aeruginosa and C. crescentus cell division (83). The concept
of a bimodal distribution of c-di-GMP in C. crescentus was not
surprising, given its asymmetric cell cycle and the PleD/TipF/
PopA localization and activity (8). In the case of P. aeruginosa,
this observation was more unexpected, as the bacterium pro-
duces morphologically similar progeny. Along this line, the
same group showed that a specific PDE (named Pch and previ-
ously identified as DipA)modulatesmotility by localizing at the
flagellated cell pole. The enzyme is thus asymmetrically parti-
tioned upon cell division to generate c-di-GMP heterogeneity
(84). Phenotypic heterogeneity in a population of genetically
identical cells has been demonstrated inmany bacterial species,
particularly for biofilm-forming bacteria. An example is the
bistable expression of the biofilmmaster regulator CsgD in Sal-
monella (85), withCsgD connected to a complex c-di-GMP-de-
pendent regulatory network. Therefore, c-di-GMP might be
instrumental for survival and persistence within a changing
environment by creating a phenotypic heterogeneous clonal
population.
Cross-talk between SecondMessengers
Although c-di-GMP is the secondmessenger associatedwith
biofilm and chronic infection, cAMP has been shown as being a
hallmark for P. aeruginosa virulence (i.e. acute infection) (86).
The dichotomy between these two second messengers is sug-
gested by the observation that increasing c-di-GMP levels, via
activation of WspR and YfiN, consequently decreases cAMP
levels via an unknown mechanism (87). Interestingly, in the
biofilm state, cAMP and c-di-GMP are observed to be spatially
organized. Indeed, bacterial cells carrying a cAMP reporter dis-
play only little activity in flow chamber-grown biofilm except
for cells in the outer layer, whereas a c-di-GMP reporter is over-
allmore active, especially at the bottomof the biofilm and in the
middle of microcolonies. Further evidence of a connection
between cAMPand c-di-GMP is given by the cAMP-dependent
regulation of the minor pilin gene pilY1, which seems to acti-
vate a signaling cascade causing the increase of c-di-GMP levels
during P. aeruginosa transition from reversible to irreversible
attachment (88). This cross-talk concept is likely to be further
expanded and might involve other small molecules such c-di-
AMP or ppGpp (89). A P. aeruginosa strain lacking (p)ppGpp is
sensitive to multiple classes of antibiotics and is defective in
biofilm formation (90). The connection between c-di-GMPand
(p)ppGpp has been recently proposed inMycobacterium smeg-
matis, where both signaling molecules may be involved in the
metabolism of glycopeptidolipids and polar lipids, leading to an
increase of the bacterium antibiotic resistance (91).
c-di-GMP Regulation of Antimicrobial Resistance
Cells in a biofilm can be up to 1000 times less susceptible to
antimicrobial agents than planktonic cells (92). The reasons for
the biofilm tolerance aremultiple, including slow growth or the
presence of an extracellular matrix (93, 94). By regulating bio-
film, c-di-GMP signaling can therefore also influence the anti-
microbial resistance of the bacterium. Recently, new c-di-
GMP-relatedmechanisms have been described to contribute to
P. aeruginosa antibiotic resistance, independently from biofilm
formation. A pel mutant strain with high c-di-GMP levels
(overexpression of the PA5487 DGC) has a higher fitness in the
presence of imipenem as compared with the same strain with
low c-di-GMP levels (PvrR PDE overexpression) (95). Sub-in-
hibitory concentrations of aminoglycosides induce biofilm for-
mation in terms of biomass but are not linked to exopolysac-
charide production. The PDE Arr has been demonstrated to be
necessary for such a response (96). Finally, lowering c-di-GMP
levels in P. aeruginosa by engineering a sagS deletion renders
the bacterium more susceptible to antibiotics, whereas this
strain is still capable of forming proper biofilms (47, 48). Fur-
thermore, upon overexpression of theAdcADGC, resistance to
antibiotics is restored to wild type levels (48).
Overall, the possibility to fight against biofilm formation,
antimicrobial resistance, and chronic infections by manipulat-
ing and subverting c-di-GMP signaling is an interesting thera-
peutic challenge (97, 98). The targets are multiple and give the
opportunity to intervene at a global level by targeting DGCs or
PDEs, or to be more clinical by aiming at specific receptors/
effectors and thus inhibit specific pathways.
Final Remarks and Future Perspectives
P. aeruginosa has come to be a remarkable model organism
for bacterial pathogenesis (2, 55, 93). Nowadays a wide variety
of technical tools are available for researchers who intend to
study this microorganism. The significant progresses that have
been made in understanding c-di-GMP-regulated phenotypes
in P. aeruginosa could therefore be applicable to other bacteria
that are relatively less easy to manipulate in the laboratory.
Importantly, despite this progress, many questions about
c-di-GMP mechanisms of action remain unanswered. The
basics of c-di-GMP metabolism have been elucidated, and we
understand most of the enzymology behind its synthesis and
degradation. However, the detailed mechanisms through
which c-di-GMP operates, and in particular the process of spe-
cific transmission, remain obscure. Identification of new c-di-
GMP receptors/effectors surely helps researchers in making
better connections between c-di-GMP signaling and functional
output. Now, have we identified all the players and their role in
the c-di-GMP contest? Surely not! In the case of the c-di-GMP
regulation of exopolysaccharide production/secretion in
P. aeruginosa, for example, although a goodnumber of involved
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DGCs/PDEs/effectors have been identified, e.g. PelD or Alg44,
how they act on the associated molecular mechanism(s)
remains to be deciphered.
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